Lesions of aryl-hydrocarbon receptor-deficient mice. 1997

P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

We have analyzed the possible role of the aryl-hydrocarbon receptor (AHR) in the aging process of mice using a homozygous null mouse (Ahr-/-) line as a model. We studied 52 male and female Ahr-/- mice aged from 6-13 months. Forty-six percent died or were ill by 13 months of age. Ahr-/- mice developed age-related lesions in several organs, some of which were apparent after only 9 months of age. Cardiovascular alterations included cardiomyopathy (100%) with hypertrophy and focal fibrosis. Vascular hypertrophy and mild fibrosis were found in the portal areas of the liver (81%), and vascular hypertrophy and mineralization were common in the uterus (70%). Gastric hyperplasia that progressed with age into polyps was evident in the pylorus of 71% of the mice over 9 months of age. Ahr-/- mice had T-cell deficiency in their spleens but not in other lymphoid organs. The immune system deficiency described previously could be the origin for the rectal prolapse found in 48% of the null mice, associated with Helicobacter hepaticus infection. In the dorsal skin (53% incidence), severe, localized, interfollicular and follicular epidermal hyperplasia, with hyperkeratosis and acanthosis, and marked dermal fibrosis, associated with the presence of anagenic hair follicles, were also evident. None of these lesions were found in 42 control (Ahr +/+ or +/-) mice of similar ages. These observations suggest that the AHR protein, in the absence of an apparent exogenous (xenobiotic) ligand, plays an important role in physiology and homeostasis in major organs in mice, and further supports an evolutionary conserved role for this transcription factor.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems

Related Publications

P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
December 2015, Biochemical pharmacology,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
April 2006, Archives of toxicology,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
November 2022, Toxicology and applied pharmacology,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
December 2009, Molecular and cellular biology,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
July 2013, Carcinogenesis,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
January 2015, EXCLI journal,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
September 2000, Proceedings of the National Academy of Sciences of the United States of America,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
September 2006, Biological chemistry,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
January 2017, Chronobiology international,
P M Fernandez-Salguero, and J M Ward, and J P Sundberg, and F J Gonzalez
February 2023, Toxicological sciences : an official journal of the Society of Toxicology,
Copied contents to your clipboard!